about
Synovial Sarcoma of the Head and Neck: A Single Institution Review.Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study.Mitochondrial DNA copy number in peripheral blood and melanoma risk.Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults.Interaction of molecular alterations with immune response in melanoma.Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons.Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience.Working with Human Tissues for Translational Cancer Research.Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.Linking Associations of Rare Low-Abundance Species to Their Environments by Association Networks.Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.Neoadjuvant immune checkpoint blockade in high-risk resectable melanomaDefining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaAuthor Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanomaThe Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer TherapyThe Influence of the Gut Microbiome on Cancer, Immunity, and Cancer ImmunotherapyImplicating or exonerating the gut microbiome in blood-borne infectionDefining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaPoor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast CancerThe microbiome, cancer, and cancer therapyFecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitisAuthor Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitisThe human tumor microbiome is composed of tumor type-specific intracellular bacteria
P50
Q33809880-2FF33DC6-93B3-4237-A56B-C30CCC8A2F09Q33839273-D1EFDFB9-F3F1-4E3A-A828-10E0A6095EA5Q35673932-60529499-1DC9-42B5-B61D-EFA1B42EB904Q38618945-43F57CAF-9340-4F22-8CE2-0C50494EEABCQ38678098-464DDF61-E46F-42E4-B7F9-A37944329655Q39329609-FC5BC02E-B407-46BF-AA7B-53527B5EDC36Q40045156-AEF50D56-AC07-47B3-8DF4-6D15EE148793Q40738166-D91183BE-A580-4C2E-AF5C-846AFB4998CAQ42721713-551AF2C7-C830-4AED-86E4-ED19D4E61674Q45162223-5BAC829E-BD18-4360-816F-EAAA8749CB93Q47447695-F778C7BC-AD66-404C-8EC7-FEA5CB30D34CQ47844531-F84E7D44-9FE2-48C4-BAE9-985DE521F91DQ48173597-1589DD7B-6F82-40AE-9035-D02DF8918994Q54974865-A209B588-146A-4B1E-81C7-3A9D0B4511BDQ55034685-9AC35D55-23AA-4C15-8294-7FC2E32E5099Q57295552-181567DB-FF92-4C64-8676-512F88F6F015Q58547062-5804202C-987B-4084-ADFC-E7D3C3AE33BAQ58561216-5602E1E4-4C3D-447F-B7D0-1D55F324473AQ58579512-FB6DA69D-2A36-4A44-B5F5-DF2B2C3EC9A0Q88318275-B032D9E5-AFFB-4987-972C-7FD1B136F37BQ90228192-67FE5A63-CD8C-4A03-ADBA-AF81BBF774B9Q91003255-333D33E5-1D86-4D3D-B891-D972E6AA1AD7Q91674143-0588EEDC-09AB-4AEE-8EFE-E5EC8A272D71Q92180014-7F28B428-85AD-430E-8902-E5F507A5583CQ93017954-EAEFF762-2E7D-41E2-9D6B-F2918DB949A8Q93386507-6097459A-1ECA-4C10-B3D1-3116A63E6329Q95936132-63D240F8-6ADC-480B-8422-A40970CD59FE
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Vancheswaran Gopalakrishnan
@en
Vancheswaran Gopalakrishnan
@nl
type
label
Vancheswaran Gopalakrishnan
@en
Vancheswaran Gopalakrishnan
@nl
prefLabel
Vancheswaran Gopalakrishnan
@en
Vancheswaran Gopalakrishnan
@nl
P31
P496
0000-0002-8704-035X